SCHEMBL20567660

SCHEMBL20567660

CC(C)(C)OC(=O)c1ccc(OCCCCCCCCCCCC(=O)O)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 3/20 0.58
GAA P10253 1/20 0.51
PLA2G4B P0C869 4/20 0.50
TP53 P04637 1/20 0.50
TSHR P16473 1/20 0.50
ALB P02768 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
HDAC1 Q13547 3/20 0.48
HDAC2 Q92769 3/20 0.48
MAPT P10636 1/20 0.47
RXRA P19793 1/20 0.47
NR1H2 P55055 1/20 0.47
NR1H3 Q13133 1/20 0.47
HDAC3 O15379 1/20 0.47
HDAC4 P56524 1/20 0.47
HDAC7 Q8WUI4 1/20 0.47
HDAC10 Q969S8 1/20 0.47
HDAC11 Q96DB2 1/20 0.47
HDAC8 Q9BY41 1/20 0.47
HDAC6 Q9UBN7 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1745096 1.00 PPARA (0.58) PPARAGAAPLA2G4BTP53TSHR
SCHEMBL26091641 1.00 PPARA (0.58) PPARAGAAPLA2G4BTP53TSHR
SCHEMBL2183439 1.00 PPARA (0.58) PPARAGAAPLA2G4BTP53TSHR
SCHEMBL4540684 1.00 PPARA (0.58) PPARAGAAPLA2G4BTP53TSHR
SCHEMBL4538607 1.00 PPARA (0.58) PPARAGAAPLA2G4BTP53TSHR
SCHEMBL557204 1.00 PPARA (0.58) PPARAGAAPLA2G4BTP53TSHR
SCHEMBL1363883 0.92 PPARA (0.51) PPARAGAAPLA2G4BTP53TSHR
SCHEMBL28155239 0.86 PPARA (0.56) PPARAGAAPLA2G4BTP53TSHR
SCHEMBL1743906 0.86 MAPT (0.53) GAATP53TSHRL3MBTL1HDAC1
SCHEMBL558993 0.86 MAPT (0.53) GAATP53TSHRL3MBTL1HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4419540-A1 IMMUNOMODULATORS Bristol-Myers Squibb Company (US) 2024-08-28 EP disclosed
CN-118159549-A Immunomodulators 百时美施贵宝公司 2024-06-07 CN disclosed
US-20230364248-A1 MIC-1 COMPOUNDS AND USES THEREOF NOVO NORDISK AS (DK) 2023-11-16 US disclosed
WO-2023069994-A1 IMMUNOMODULATORS BRISTOL-MYERS SQUIBB COMPANY (US) 2023-04-27 WO disclosed
WO-2023069994-A1 IMMUNOMODULATORS BRISTOL-MYERS SQUIBB COMPANY (US) 2023-04-27 WO disclosed
CN-111183148-A MIC-1 compounds and uses thereof 诺和诺德股份有限公司 2020-05-19 CN disclosed
EP-3630805-A1 MIC-1 COMPOUNDS AND USES THEREOF Novo Nordisk A/S (DK) 2020-04-08 EP disclosed
US-20200079829-A1 MIC-1 COMPOUNDS AND USES THEREOF NOVO NORDISK A/S (DK) 2020-03-12 US disclosed
US-10398782-B2 MIC-1 compounds and uses thereof NOVO NORDISK A/S (DK) 2019-09-03 US disclosed
WO-2018215525-A1 MIC-1 COMPOUNDS AND USES THEREOF NOVO NORDISK A/S (DK) 2018-11-29 WO disclosed
US-20180339057-A1 MIC-1 Compounds and Uses Thereof NOVO NORDISK A/S (DK) 2018-11-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200079829-A1 MIC-1 COMPOUNDS AND USES THEREOF IMMT, MICA, TAP1 PPARA 2549/4885GAA 3121/4885PLA2G4B 4779/4885
US-10398782-B2 MIC-1 compounds and uses thereof IMMT, MICA, TAP1 PPARA 2549/4885GAA 3121/4885PLA2G4B 4779/4885
US-20230364248-A1 MIC-1 COMPOUNDS AND USES THEREOF IMMT, MICA, TAP1 PPARA 2549/4885GAA 3121/4885PLA2G4B 4779/4885
US-20180339057-A1 MIC-1 Compounds and Uses Thereof IMMT, MICA, TAP1 PPARA 2549/4885GAA 3121/4885PLA2G4B 4779/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.